Captopril-induced reduction of serum levels of transforming growth Factor-β1 correlates with long-term renoprotection in insulin-dependent diabetic patients

This publication has 22 references indexed in Scilit:

• Diabetic Nephropathy
  Diabetes Care, 1998
• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
  The Lancet, 1997
• The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist
  American Journal of Kidney Diseases, 1997
• Understanding the nature of renal disease progression
  Kidney International, 1997
• Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.
  Journal of Clinical Investigation, 1994
• Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta.
  Journal of Clinical Investigation, 1994
• The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
  New England Journal of Medicine, 1993
• Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.
  Journal of Clinical Investigation, 1993
• Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
  Journal of Clinical Investigation, 1992
• The influence of glucose concentration on angiotensin II-induced hypertrophy of proximal tubular cells in culture
  Biochemical and Biophysical Research Communications, 1991